Pfizer Partners with Chai Discovery to Accelerate AI-Powered Drug Discovery
SAN FRANCISCO, June 4 2026 Chai Discovery has announced a strategic license agreement with Pfizer that will enable the...
pharma innovation
Advertisement
Fathom Therapeutics Raises $47M to Advance AI Drug Design
NEW YORK, April 27, 2026 Fathom Therapeutics has announced the successful completion of an oversubscribed $47 million Series A...
AI Transforms Pharma R&D and Manufacturing Models
London, United Kingdom | March 23, 2026 The pharmaceutical industry is undergoing a profound transformation as artificial intelligence (AI),...
Lupin Wins U.S. FDA Approval for First Nanomi LAI Injectable
September 3, 2025 – Mumbai & Naples – Lupin Limited announced U.S. FDA approval for its Risperidone extended-release injectable...
PharmaResearch and Laboratoires VIVACY Forge Strategic Alliance to Distribute REJURAN Across Europe
PharmaResearch, a regenerative medicine company headquartered in South Korea, has entered a strategic distribution partnership with France-based Laboratoires VIVACY,...
Advertisements
RNAConnect® Launches UltraMarathonRT® Kit to Transform Short-Read RNA Sequencing
RNAConnect today announced the commercial launch of the UltraMarathonRT® (uMRT) cDNA Synthesis and Amplification Kit, a next-generation tool designed...
American Regent Debuts Gvoke VialDx, Innovative Glucagon for Radiology
SHIRLEY, N.Y., August 27, 2025 — American Regent, Inc.® has announced the commercial launch of Gvoke VialDx™ (glucagon injection),...
Advertisement
